News and Press Releases
SMC Ltd Announces Expansion of Sterile Fill Finish Capabilities, Unveiling State-of-the-Art Facility in North Carolina, US
26 March 2024 -- Wisconsin, US -- SMC Ltd, the worldwide contract manufacturer of single use and disposable medical devices, has today announced the acquisition of an end-to-end fill/finish facility...
Category: Manufacturing and Packing
Posted: March 26, 2024
Recipharm attains major sustainability milestones
Approval of ambitious Greenhouse Gas emission reduction targets by SBTi Commitment to renewable electricity sourcing to 100.0% by 2024 and to 42.1% GHG emission reduction (Scope 1 and 2) by...
Category: Manufacturing and Packing
Posted: March 26, 2024
Gilbert To Officially Open New Development and GMP Manufacturing Facility
22 March 2024 -- Nottingham, UK -- UK-based contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions was joined by Oxford/AstraZeneca COVID-19 vaccine co-inventor Professor Dame Sarah Gilbert, biotech industry representatives and...
Category: BioManufacturing, Clinical Trials, Manufacturing and Packing
Posted: March 22, 2024
Albert Einstein Centre, Nottingham Science Park, Nottingham, UK, NG7 2TN
Viroclinics-DDL Changes Name to Cerba Research
14 March 2024 -- Rotterdam, the Netherlands -- Viroclinics-DDL (referred to herein as Cerba Research, the Netherlands), a world leading vaccine and antiviral specialty laboratory providing research and clinical trial...
Category: Biotechnology, Clinical Trials
Posted: March 15, 2024
Coriolis Pharma Adds Analytical Ultracentrifugation for Release Testing to its Service Offerings
Coriolis Pharma offers Analytical Ultracentrifugation (AUC) for biologics and virus-based drug products from early-stage development to post-market monitoring. Coriolis is now preparing for inspection by the competent surveillance authority for...
Category: Manufacturing and Packing
Posted: March 6, 2024
Global Clinical Trial Supply Leader partners with Pill Connect to deliver greater confidence in clinical trial outcomes
5 March 2024 -- Manchester, UK -- Pill Connect, the smart dosing device company, today announces its acceptance onto the leading CDMO’s (Contract development and manufacturing organisation) smart packaging supply...
Category: Clinical Trials, Drug Delivery, Logistics
Posted: March 5, 2024
Epsilogen and Lonza Announce Successful Large-Scale GMP Manufacturing of MOv18, an IgE Antibody Targeting Ovarian Cancer
First time GMP manufacturing of a therapeutic IgE antibody has been achieved at scale GMP material to be used in phase 1b study in platinum-resistant ovarian cancer (PROC) patients scheduled...
Category: BioManufacturing
Posted: March 5, 2024
Kite Presents New Data for Yescarta (axicabtagene ciloleucel) CAR T-cell Therapy Highlighting Manufacturing Excellence and Cost-Effectiveness in the US
Data Highlights Industry-leading Manufacturing Success Rates for US Axicabtagene Ciloleucel Patients from Launch to Present Data Also Supports Cost-effectiveness of Axicabtagene Ciloleucel Versus Bispecific Antibodies 16 February 2024 – Stockley...
Category: BioManufacturing
Posted: February 21, 2024
Global End-to-End Solutions Partner to Life Sciences Organisations, AscellaHealth, joins Manchester Science Park
20 February 2024 -- Manchester, UK -- Global healthcare and specialty pharmacy solutions company providing innovative solutions to life sciences and biotech manufacturers, AscellaHealth, is expanding its UK presence with...
Category: Manufacturing and Packing
Posted: February 20, 2024
AscellaHealth, LLC 1055 Westlakes Drive Suite 175 Berwyn, PA 19312, US
argenx Announces MHRA Licensing of Subcutaneous VYVGART (efgartigimod alfa) for generalised Myasthenia Gravis
VYVGART is now licensed for both intravenous (IV) and self-administered subcutaneous (SC) use in the UK 7 February 2024 -- Gerrards Cross, UK -- argenx UK, part of argenx, a...
Category: Biotechnology
Posted: February 7, 2024
Spaces Gerrards Cross Chalfont Park, Building 1 Gerrards Cross, SL9 0BG
Recipharm, Medspray and Resyca enter into exclusive license agreement to develop nasally-delivered drug products using proprietary soft mist technology
Partnership will help bring breakthroughs in the nasal delivery of fragile biologics and small molecules to market 23 January 2023 -- Stockholm, Sweden -- Recipharm, a leading contract development and...
Category: Drug Delivery
Posted: January 23, 2024
Vetter Becomes a Member of the German Association of Research-Based Pharmaceutical Companies (vfa)
Globally operating CDMO committed to strengthening Germany as a research and production location Association grants Vetter extraordinary membership vfa recognises the importance of pharmaceutical service providers in drug development and...
Category: Biotechnology, Pharmaceutical
Posted: January 17, 2024
New partnership aims to advance vaccine against MERS coronavirus
CEPI to invest up to $47m to develop and stockpile a ready reserve of emergency MERS vaccine candidate, VTP-500 VTP-500 project with Barinthus Bio and University of Oxford, UK, uses...
Category: Clinical Trials
Posted: January 2, 2024
Newly established 3PARL consortium to assure global life sciences industry of consistent high standard of GMP supply chain audits
Rephine and Eurofins Healthcare are acting against substandard audit practices with guarantees of the highest quality of inspection services & library reports, from raw materials to finished products 24 October...
Category: Other
Posted: October 25, 2023
Additional Analytical Laboratory and Spray Drying Investments
5 October 2023 -- New Jersey, US -- Experic, a contract development and manufacturing organisation (CDMO) and clinical supply services company serving the biopharmaceutical industry, announced today the successful completion of...
Category: Manufacturing and Packing
Posted: October 5, 2023
